Predicting benefit from adjuvant therapy in colon cancer

摘要: Colorectal cancer is a significant cause of morbidity and mortality despite recent advances in therapy. Given the variety options that exist for treatment metastatic colorectal fact resistance to any single approach common, need identify predictors response specific therapies urgent. This particularly critical adjuvant setting where stakes are highest terms both cure treatment-associated toxicities. In this manuscript, we review some putative markers prognosis effects ultimately may play role selection patients treatments therapy cancer, with focus on developments ongoing clinical trials.